Sequential Combo Immuno and Target Therapy (SECOMBIT) Study

Clinical trial NCT02631447 · COMPLETED

Trial details

NCT number: NCT02631447
Sponsor: Fondazione Melanoma Onlus
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Melanoma

Start date: 2016-11-14
Primary completion: 2024-05-31
Enrollment: 251

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.